4 May 2016 - PHARMAC is seeking feedback on a proposal to amend the funding restrictions for rituximab in DHB hospitals.

In summary, this proposal would result in rituximab being funded in DHB hospitals for children with steroid dependent, frequently relapsing and steroid resistant nephrotic syndrome from 1 July 2016; subject to hospital medicines list restrictions.

For more details, go to: http://www.pharmac.govt.nz/news/consultation-2016-05-04-rituximab/